Article Details

VBL Therapeutics Treats First Patient in Phase 2 Randomized Controlled Study of VB-201 in ...

Retrieved on: 2021-01-27 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

VBL Therapeutics Treats First Patient in Phase 2 Randomized Controlled Study of VB-201 in .... View article details on hiswai:

Excerpt

VB-201 is designed to offer differentiation from other immune modulators ... By modulating innate immunity, the controller of the immune system, ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo